BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bhave G, Lewis JB, Chang SS. Association of gadolinium based magnetic resonance imaging contrast agents and nephrogenic systemic fibrosis. J Urol 2008;180:830-5; discussion 835. [PMID: 18635232 DOI: 10.1016/j.juro.2008.05.005] [Cited by in Crossref: 50] [Cited by in F6Publishing: 38] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Okubo H, Kokubu S, Komiyama M, Yamagata H, Uchiyama A, Miyazaki A, Watanabe S. Radiofrequency ablation of hepatocellular carcinoma: The feasibility of magnetic resonance imaging with gadolinium ethoxybenzyl diethylene triamine pentaacetic acid for evaluating the ablative margin: Gd-EOB-DTPA for ablative margin of liver ablation. Hepatology Research 2010;40:1034-41. [DOI: 10.1111/j.1872-034x.2010.00709.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
2 Tartaglione G, Townsend DM, Bassi PF, Delgado Bolton RC, Giammarile F, Rubello D. Diuresis renography in equivocal urinary tract obstruction. A historical perspective. Biomed Pharmacother 2019;116:108981. [PMID: 31136948 DOI: 10.1016/j.biopha.2019.108981] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
3 Lange S, Mędrzycka-Dąbrowska W, Zorena K, Dąbrowski S, Ślęzak D, Malecka-Dubiela A, Rutkowski P. Nephrogenic Systemic Fibrosis as a Complication after Gadolinium-Containing Contrast Agents: A Rapid Review. Int J Environ Res Public Health 2021;18:3000. [PMID: 33804005 DOI: 10.3390/ijerph18063000] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Dambreville S, Chapman AB, Torres VE, King BF, Wallin AK, Frakes DH, Yoganathan AP, Wijayawardana SR, Easley K, Bae KT, Brummer ME; Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP). Renal arterial blood flow measurement by breath-held MRI: Accuracy in phantom scans and reproducibility in healthy subjects. Magn Reson Med 2010;63:940-50. [PMID: 20373395 DOI: 10.1002/mrm.22278] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
5 Chotenimitkhun R, Hundley WG. Pharmacological stress cardiovascular magnetic resonance. Postgrad Med 2011;123:162-70. [PMID: 21566427 DOI: 10.3810/pgm.2011.05.2295] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
6 De León-Rodríguez LM, Martins AF, Pinho MC, Rofsky NM, Sherry AD. Basic MR relaxation mechanisms and contrast agent design. J Magn Reson Imaging 2015;42:545-65. [PMID: 25975847 DOI: 10.1002/jmri.24787] [Cited by in Crossref: 98] [Cited by in F6Publishing: 76] [Article Influence: 16.3] [Reference Citation Analysis]
7 Zanardo M, Sardanelli F, Rainford L, Monti CB, Murray JG, Secchi F, Cradock A. Technique and protocols for cardiothoracic time-resolved contrast-enhanced magnetic resonance angiography sequences: a systematic review. Clin Radiol 2021;76:156.e9-156.e18. [PMID: 33008622 DOI: 10.1016/j.crad.2020.08.028] [Reference Citation Analysis]
8 Mühlenweg M, Schaefers G, Trattnig S. [Physical interactions in MRI: Some rules of thumb for their reduction]. Radiologe 2015;55:638-48. [PMID: 26220127 DOI: 10.1007/s00117-015-2812-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
9 Vivero-Escoto JL, Rieter WJ, Lau H, Huxford-Phillips RC, Lin W. Biodegradable polysilsesquioxane nanoparticles as efficient contrast agents for magnetic resonance imaging. Small 2013;9:3523-31. [PMID: 23613450 DOI: 10.1002/smll.201300198] [Cited by in Crossref: 52] [Cited by in F6Publishing: 48] [Article Influence: 6.5] [Reference Citation Analysis]
10 Chan FP. MR and CT Imaging of the Pediatric Patient with Structural Heart Disease. Seminars in Thoracic and Cardiovascular Surgery 2008;20:393-9. [DOI: 10.1053/j.semtcvs.2008.11.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
11 Pula JH, Reder AT. Multiple sclerosis. Part I: neuro-ophthalmic manifestations. Curr Opin Ophthalmol 2009;20:467-75. [PMID: 19809319 DOI: 10.1097/ICU.0b013e328331913b] [Cited by in Crossref: 17] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
12 Arian M, Zamanian A, Taheri S. Highly water-dispersible calcium lignosulfonate-capped MnO nanoparticles as a T1 MRI contrast agent with exceptional colloidal stability, low toxicity and remarkable relaxivity. RSC Adv 2019;9:40498-506. [DOI: 10.1039/c9ra09125d] [Reference Citation Analysis]
13 Matsumoto Y, Mitsuhashi Y, Monma F, Kawaguchi M, Suzuki T, Miyabe C, Igarashi A, Tsuboi R. Nephrogenic systemic fibrosis: a case report and review on Japanese patients. J Dermatol 2012;39:449-53. [PMID: 22035371 DOI: 10.1111/j.1346-8138.2011.01407.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
14 Bennett KM, Jo J, Cabral H, Bakalova R, Aoki I. MR imaging techniques for nano-pathophysiology and theranostics. Advanced Drug Delivery Reviews 2014;74:75-94. [DOI: 10.1016/j.addr.2014.04.007] [Cited by in Crossref: 45] [Cited by in F6Publishing: 37] [Article Influence: 6.4] [Reference Citation Analysis]
15 Hecht S, Adams WH. MRI of Brain Disease in Veterinary Patients Part 1: Basic Principles and Congenital Brain Disorders. Veterinary Clinics of North America: Small Animal Practice 2010;40:21-38. [DOI: 10.1016/j.cvsm.2009.09.005] [Cited by in Crossref: 28] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
16 Brucher N, Vial J, Baunin C, Labarre D, Meyrignac O, Juricic M, Bouali O, Abbo O, Galinier P, Sans N. Non-contrast-enhanced MR angiography using time-spin labelling inversion pulse technique for detecting crossing renal vessels in children with symptomatic ureteropelvic junction obstruction: comparison with surgical findings. Eur Radiol 2016;26:2697-704. [DOI: 10.1007/s00330-015-4065-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
17 Poonaki E, Esfandyar M, Hejazinia H, Sadat Ebrahimi SE, Pirali Hamedani M, Farzaneh J, Shafiee Ardestani M. N-acetylcysteine-PLGA nano-conjugate: effects on cellular toxicity and uptake of gadopentate dimeglumine. IET Nanobiotechnol 2020;14:470-8. [PMID: 32755956 DOI: 10.1049/iet-nbt.2019.0374] [Reference Citation Analysis]
18 Park SY, Kim CK, Kim E, Park BK. Noncontrast-enhanced magnetic resonance renal angiography using a repetitive artery and venous labelling technique at 3 T: comparison with contrast-enhanced magnetic resonance angiography in subjects with normal renal function. Eur Radiol 2015;25:533-40. [DOI: 10.1007/s00330-014-3416-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
19 Vivero-Escoto JL, Taylor-Pashow KM, Huxford RC, Della Rocca J, Okoruwa C, An H, Lin W, Lin W. Multifunctional mesoporous silica nanospheres with cleavable Gd(III) chelates as MRI contrast agents: synthesis, characterization, target-specificity, and renal clearance. Small. 2011;7:3519-3528. [PMID: 22069305 DOI: 10.1002/smll.201100521] [Cited by in Crossref: 82] [Cited by in F6Publishing: 76] [Article Influence: 8.2] [Reference Citation Analysis]
20 Stachler RJ, Chandrasekhar SS, Archer SM, Rosenfeld RM, Schwartz SR, Barrs DM, Brown SR, Fife TD, Ford P, Ganiats TG, Hollingsworth DB, Lewandowski CA, Montano JJ, Saunders JE, Tucci DL, Valente M, Warren BE, Yaremchuk KL, Robertson PJ. Clinical Practice Guideline: Sudden Hearing Loss. Otolaryngol Head Neck Surg 2012;146:S1-S35. [DOI: 10.1177/0194599812436449] [Cited by in Crossref: 545] [Cited by in F6Publishing: 414] [Article Influence: 60.6] [Reference Citation Analysis]
21 Revel MP, Sanchez O, Lefort C, Meyer G, Couchon S, Hernigou A, Niarra R, Chatellier G, Frija G. Diagnostic accuracy of unenhanced, contrast-enhanced perfusion and angiographic MRI sequences for pulmonary embolism diagnosis: results of independent sequence readings. Eur Radiol 2013;23:2374-82. [DOI: 10.1007/s00330-013-2852-8] [Cited by in Crossref: 25] [Cited by in F6Publishing: 17] [Article Influence: 3.1] [Reference Citation Analysis]
22 Galperin TA, Cronin AJ, Leslie KS. Cutaneous manifestations of ESRD. Clin J Am Soc Nephrol. 2014;9:201-218. [PMID: 24115194 DOI: 10.2215/cjn.05900513] [Cited by in Crossref: 32] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
23 Sundgren PC, Leander P. Is administration of gadolinium-based contrast media to pregnant women and small children justified? J Magn Reson Imaging 2011;34:750-7. [PMID: 21928308 DOI: 10.1002/jmri.22413] [Cited by in Crossref: 60] [Cited by in F6Publishing: 44] [Article Influence: 6.7] [Reference Citation Analysis]
24 Dwyer JP, Greco BA, Lewis JB. Evaluation of Renal Artery Stenosis in Dialysis Patients. Seminars in Dialysis 2009;22:519-23. [DOI: 10.1111/j.1525-139x.2009.00618.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
25 Zhang B, Liang L, Chen W, Liang C, Zhang S. An Updated Study to Determine Association between Gadolinium-Based Contrast Agents and Nephrogenic Systemic Fibrosis. PLoS One 2015;10:e0129720. [PMID: 26076348 DOI: 10.1371/journal.pone.0129720] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
26 Lunyera J, Mohottige D, Alexopoulos AS, Campbell H, Cameron CB, Sagalla N, Amrhein TJ, Crowley MJ, Dietch JR, Gordon AM, Kosinski AS, Cantrell S, Williams JW Jr, Gierisch JM, Ear B, Goldstein KM. Risk for Nephrogenic Systemic Fibrosis After Exposure to Newer Gadolinium Agents: A Systematic Review. Ann Intern Med 2020;173:110-9. [PMID: 32568573 DOI: 10.7326/M20-0299] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
27 Lattanzio SM. The gadolinium hypothesis for fibromyalgia and unexplained widespread chronic pain. Med Hypotheses 2019;129:109240. [PMID: 31371082 DOI: 10.1016/j.mehy.2019.109240] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
28 Christensen KN, Lee CU, Hanley MM, Leung N, Moyer TP, Pittelkow MR. Quantification of gadolinium in fresh skin and serum samples from patients with nephrogenic systemic fibrosis. Journal of the American Academy of Dermatology 2011;64:91-6. [DOI: 10.1016/j.jaad.2009.12.044] [Cited by in Crossref: 44] [Cited by in F6Publishing: 38] [Article Influence: 4.4] [Reference Citation Analysis]
29 Fujita T, Saito K, Kashiwagi N, Sato M, Seo T, Doi K. The prevalence of vestibular schwannoma among patients treated as sudden sensorineural hearing loss. Auris Nasus Larynx 2019;46:78-82. [PMID: 30042019 DOI: 10.1016/j.anl.2018.06.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
30 Tsushima Y, Kanal E, Thomsen HS. Nephrogenic systemic fibrosis: risk factors suggested from Japanese published cases. Br J Radiol 2010;83:590-5. [PMID: 20413447 DOI: 10.1259/bjr/17689538] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
31 Parienty I, Rostoker G, Jouniaux F, Piotin M, Admiraal-Behloul F, Miyazaki M. Renal artery stenosis evaluation in chronic kidney disease patients: nonenhanced time-spatial labeling inversion-pulse three-dimensional MR angiography with regulated breathing versus DSA. Radiology 2011;259:592-601. [PMID: 21330564 DOI: 10.1148/radiol.11101422] [Cited by in Crossref: 36] [Cited by in F6Publishing: 26] [Article Influence: 3.6] [Reference Citation Analysis]
32 Pan D, Senpan A, Caruthers SD, Williams TA, Scott MJ, Gaffney PJ, Wickline SA, Lanza GM. Sensitive and efficient detection of thrombus with fibrin-specific manganese nanocolloids. Chem Commun (Camb) 2009;:3234-6. [PMID: 19587924 DOI: 10.1039/b902875g] [Cited by in Crossref: 42] [Cited by in F6Publishing: 35] [Article Influence: 3.5] [Reference Citation Analysis]
33 Cina A, Di Stasi C, Semeraro V, Marano R, Savino G, Iezzi R, Bonomo L. Comparison of CT and MR angiography in evaluation of peripheral arterial disease before endovascular intervention. Acta Radiol 2016;57:547-56. [DOI: 10.1177/0284185115595657] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
34 Chan FP. MR and CT imaging of the pediatric patient with structural heart disease. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2009;:99-105. [PMID: 19349022 DOI: 10.1053/j.pcsu.2009.01.009] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
35 Wadas TJ, Sherman CD, Miner JH, Duncan JR, Anderson CJ. The biodistribution of [153Gd]Gd-labeled magnetic resonance contrast agents in a transgenic mouse model of renal failure differs greatly from control mice. Magn Reson Med 2010;64:1274-80. [PMID: 20648683 DOI: 10.1002/mrm.22553] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
36 Revel MP, Sanchez O, Couchon S, Planquette B, Hernigou A, Niarra R, Meyer G, Chatellier G. Diagnostic accuracy of magnetic resonance imaging for an acute pulmonary embolism: results of the 'IRM-EP' study. J Thromb Haemost 2012;10:743-50. [PMID: 22321816 DOI: 10.1111/j.1538-7836.2012.04652.x] [Cited by in Crossref: 68] [Cited by in F6Publishing: 48] [Article Influence: 7.6] [Reference Citation Analysis]
37 El-Dakdouki MH, El-Boubbou K, Kamat M, Huang R, Abela GS, Kiupel M, Zhu DC, Huang X. CD44 targeting magnetic glyconanoparticles for atherosclerotic plaque imaging. Pharm Res 2014;31:1426-37. [PMID: 23568520 DOI: 10.1007/s11095-013-1021-8] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 4.6] [Reference Citation Analysis]
38 Poisson JL, Low A, Park YA. The treatment of nephrogenic systemic fibrosis with therapeutic plasma exchange: Treatment of Nephrogenic Systemic Fibrosis With TPE. J Clin Apheresis 2013;28:317-20. [DOI: 10.1002/jca.21253] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]